Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-15

Clinical Trial Update: Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of mepolizumab for Churg-Strauss syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mepolizumab (mepolizumab)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Churg Strauss Syndrome | Phase 2 | Status: COMPLETED